Biggest challenge during pandemic was negotiating politics: Pfizer

Protectionism as a result of fear meant the governments closed down borders, making it difficult to export vaccines, says Albert Bourla, Pfizer's chief executive officer


Pfizer CEO Albert Bourla

Pfizer’s chief executive says the biggest challenge the company and other vaccine-makers faced during the pandemic was negotiating the politics.

Albert Bourla, who was speaking on Thursday on a panel on pandemic preparedness at the World Economic Forum gathering in Davos, Switzerland, said mask-wearing, vaccine efficacy or questions about delivering the vaccines were all politicised and were constant obstacles for vaccine-makers.

He says “the biggest challenge ... was the political challenge”. He added that protectionism as a result of fear meant the governments closed down borders, making it difficult to export vaccines or bring in raw materials needed to make them.

Meanwhile, 39 organisations from nine countries, including Salesforce, Pfizer and AstraZeneca, have pledged to close gaps on global health equity. Those having signed the Global Health Equity Network Zero Health Gaps Pledge at the WEF Annual Meeting


Also Read

WEF 2023: Davos gears up for world leaders' biggest post-pandemic gathering

PwC India completes acquisition of Venerate Solutions Private Ltd

Those hired during pandemic 'facing lower productivity': Salesforce Co-CEO

Adityanath first UP CM to attend World Economic Forum meet in Davos

Davos 2023: CEOs buzz about ChatGPT-style AI at World Economic Forum

Xi Jinping says China's Covid-19 fight in new stage, faces tough tasks

Charges filed against Alec Baldwin for firing accident; may face 5-yr jail

FBI chief Wray says he's 'deeply concerned' by China's AI program

Nepal PM Prachanda meets families of those killed in Yeti plane crash

Strikes, protests test French govt's plan to raise retirement age to 64

First Published: Jan 20 2023 | 12:46 AM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on are available only to BS Premium subscribers. Already a BS Premium subscriber?LOGIN NOW

Register to